← Evidence map

ArticlePharmaceutics2023

Satisfying QTPP of Erythropoietin Biosimilar by QbD through DoE-Derived Downstream Process Engineering.

Kakon Nag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37631301